Cargando…
Optimisation of a Novel Bio-Substrate as a Treatment for Atrophic Age-Related Macular Degeneration
Atrophic age-related macular degeneration (AMD) is the most common form of AMD accounting for 90% of patients. During atrophic AMD the waste/exchange pathway between the blood supply (choroid) and the retinal pigment epithelium (RPE) is compromised. This results in atrophy and death of the RPE cells...
Autores principales: | McCormick, Rachel, Pearce, Ian, Kaye, Stephen, Haneef, Atikah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243032/ https://www.ncbi.nlm.nih.gov/pubmed/32500067 http://dx.doi.org/10.3389/fbioe.2020.00456 |
Ejemplares similares
-
Application and mechanism of anti-VEGF drugs in age-related macular degeneration
por: Song, Dawei, et al.
Publicado: (2022) -
Rethinking the potential and necessity of drug delivery systems in neovascular age-related macular degeneration therapy
por: Huang, Xi, et al.
Publicado: (2023) -
Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part II: Cell and Tissue Engineering Therapies
por: Jemni-Damer, Nahla, et al.
Publicado: (2020) -
Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part I: Biomaterials-Based Drug Delivery Devices
por: Jemni-Damer, Nahla, et al.
Publicado: (2020) -
Human Salivary Histatin-1 Promotes Osteogenic Cell Spreading on Both Bio-Inert Substrates and Titanium SLA Surfaces
por: Sun, Wei, et al.
Publicado: (2020)